Inlive

Inlive is an original preventive vaccine in the world, independently developed by Sinovac Biotech Ltd., which is mainly used to prevent the Hand-Foot-Month Disease(HFMD) caused by Enterovirus Type 71(EV71) under 3 years old. The research of EV71 vaccine was initiated in May, 2008.Through close collaborations with China Food and Drug Administration (CFDA), Centers for Disease Control and Prevention (CDCs) and well-known research institutions, it costed us 8 years with extensive capital investment to complete the pre-clinical research, clinical trials (Phase I - Phase III), and commercial plant. In December 2015, Inlive was approved to be commercialized in China.